Biomarkers and Neuroimaging in Multiple Sclerosis and Neuromyelitis Optica
Multiple sclerosis is a clinically heterogeneous disorder for which it is difficult to predict the clinical course.
Our interest centers on identifying biologic, genetic and neuroimaging markers that will offer early and accurate diagnosis and that will also predict the future clinical course of the disease.
For example, we are developing new neuroimaging techniques by making use of non-conventional magnetic resonance imaging. These techniques offer important information about the pathophysiologic processes associated with severe forms of multiple sclerosis and provides data predictive of future disability. Also, these techniques permits the in vivo detection of neurodegeneration and allows evaluation of disease progression.
The final objective of our group is to translate the future results of these studies into routine clinical practice to assist in establishing both rapid diagnosis and determination of the most appropriate therapeutic strategy for each patient.
- Immunopathogenesis of Paraneoplastic Neurologic Syndrome
- Pathogenesis of Immune-mediated Neurological Disorders
- Pathogenesis and Novel Therapies in Multiple Sclerosis
- Biomarkers and Neuroimaging in Multiple Sclerosis and Neuromyelitis Optica
- Neuroimmunologic Response to Surgical Aggression and Anesthesia
- Visual Pathway Laboratory
- Clinical Muticentric Prospective Studies